share_log

Vertical Research Downgrades RXO to Hold, Announces $23 Price Target

Benzinga ·  Jan 10 23:37

Vertical Research analyst Jeffrey Kauffman downgrades RXO (NYSE:RXO) from Buy to Hold and announces $23 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment